A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects
Clinical trial NCT04135898 · COMPLETED
Trial details
- NCT number
- NCT04135898
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-23
- Primary completion
- 2020-03-16
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.